Literature DB >> 32611577

Towards individualized radiation therapy in multiple myeloma.

Felix Momm1, Christine Greil2, Henning Schäfer3.   

Abstract

Entities:  

Year:  2020        PMID: 32611577      PMCID: PMC7327648          DOI: 10.3324/haematol.2019.243451

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Spine stereotactic radiosurgery for the treatment of multiple myeloma.

Authors:  Jacob A Miller; Ehsan H Balagamwala; Samuel T Chao; Todd Emch; John H Suh; Toufik Djemil; Lilyana Angelov
Journal:  J Neurosurg Spine       Date:  2016-10-28

2.  New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity.

Authors:  Adnan Elhammali; Behrang Amini; Ethan B Ludmir; Jillian R Gunther; Sarah A Milgrom; Chelsea C Pinnix; Therese Andraos; Alison Yoder; Donna Weber; Robert Orlowski; Elisabet Manasanch; Krina Patel; Paolo Strati; Ranjit Nair; Hans C Lee; Sheeba Thomas; Swaminathan Iyer; Gregory Kaufmann; Naveen Garg; Bouthaina S Dabaja
Journal:  Haematologica       Date:  2020-01-09       Impact factor: 9.941

Review 3.  Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.

Authors:  Richard W Tsang; Belinda A Campbell; Jayant S Goda; Chris R Kelsey; Youlia M Kirova; Rahul R Parikh; Andrea K Ng; Umberto Ricardi; Chang-Ok Suh; Peter M Mauch; Lena Specht; Joachim Yahalom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-20       Impact factor: 7.038

4.  Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.

Authors:  Vanessa Piechotta; Tina Jakob; Peter Langer; Ina Monsef; Christof Scheid; Lise J Estcourt; Sunday Ocheni; Sebastian Theurich; Kathrin Kuhr; Benjamin Scheckel; Anne Adams; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2019-11-25

5.  A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression.

Authors:  Dirk Rades; Antonio Jose Conde-Moreno; Jon Cacicedo; Theo Veninga; Niklas Gebauer; Tobias Bartscht; Steven E Schild
Journal:  BMC Cancer       Date:  2016-04-25       Impact factor: 4.430

6.  Establishment of an innovative staging system for extramedullary plasmacytoma.

Authors:  Qian Zhu; Xiong Zou; Rui You; Rou Jiang; Meng-Xia Zhang; You-Ping Liu; Chao-Nan Qian; Hai-Qiang Mai; Ming-Huang Hong; Ling Guo; Ming-Yuan Chen
Journal:  BMC Cancer       Date:  2016-10-08       Impact factor: 4.430

Review 7.  Stem-cell transplantation in multiple myeloma: how far have we come?

Authors:  Cinnie Y Soekojo; Shaji K Kumar
Journal:  Ther Adv Hematol       Date:  2019-11-14
  7 in total
  3 in total

1.  The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma.

Authors:  Anthony D Nehlsen; Kunal K Sindhu; Erin Moshier; Joshua Richter; Shambavi Richard; Ajai Chari; Larysa Sanchez; Samir Parekh; Hearn Jay Cho; Sundar Jagannath; Kavita Dharmarajan
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2021-09-24

2.  RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment.

Authors:  Andrea Emanuele Guerini; Alessandra Tucci; Filippo Alongi; Eneida Mataj; Angelo Belotti; Paolo Borghetti; Luca Triggiani; Ludovica Pegurri; Sara Pedretti; Marco Bonù; Davide Tomasini; Jessica Imbrescia; Alessandra Donofrio; Giorgio Facheris; Navdeep Singh; Giulia Volpi; Cesare Tomasi; Stefano Maria Magrini; Luigi Spiazzi; Michela Buglione
Journal:  Cancers (Basel)       Date:  2022-05-02       Impact factor: 6.575

3.  Radiotherapy Response Assessment of Multiple Myeloma: A Dual-Energy CT Approach With Virtual Non-Calcium Images.

Authors:  Philipp Fervers; Erkan Celik; Grischa Bratke; David Maintz; Christian Baues; Simon Ruffing; Philip Pollman-Schweckhorst; Jonathan Kottlors; Simon Lennartz; Nils Große Hokamp
Journal:  Front Oncol       Date:  2021-09-23       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.